Delivery Order SPE2DB22D3004-SPE2DB24FQT33
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, for the delivery of Envarsus XR 1 mg tablets. The contract, valued at $1,216.11, is a firm fixed-price delivery order with a period of performance through July 5, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025....
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $4,845.99 firm fixed price delivery order is for the supply of Envarsus XR 4 mg tablets. The contract has an ultimate completion date of July 12, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999.00 through December 31, 2025. This...
- This federal contract award, valued at $1,615.33, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Envarsus XR 4 mg tablets, a specialty pharmaceutical product, with a period of performance through November 18, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, for the delivery of Envarsus XR 1 mg tablets. The contract, valued at $1,465.68, was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to serve the Department of Defense (DoD) and other government agencies. The award is a delivery order under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA, which has a ceiling value of up to...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the provision of the pharmaceutical product Envarsus XR 1 mg tablet, with a ceiling value of $1,099.26. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, which is part of the Department of Defense, and has an ultimate completion date of May 6, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office division is for the supply of pharmaceutical product Envarsus XR 1 mg tablet to the U.S. federal government. The award, valued at $1,832.10, was made by the Medical Supply Chain, a component of the Defense Logistics Agency (DLA), which is part of the Department of Defense. Amerisourcebergen, a major pharmaceutical distribution company, holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Envarsus XR 4 mg tablets. The contract, valued at $1,615.33, is a firm-fixed price delivery order with a completion date of November 5, 2024. Amerisourcebergen has been awarded multiple indefinite delivery contracts (IDCs) with the DLA Troop Support Medical and the Department of Justice Federal Bureau of Investigation, valued up to...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division provides for the delivery of the pharmaceutical product Envarsus XR 1 mg tablet to the U.S. government. The $1,465.68 firm fixed price contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical and has a completion date of May 6, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to federal agencies, particularly the Department of Defense (DoD) and...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,423.90 Firm Fixed Price Delivery Order contract is for the supply of ENVARSUS XR 4 MG TABLET 100S, a pharmaceutical product. The contract has an ultimate completion date of February 10, 2025 and was awarded on January 17, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $7,884.42 to provide Envarsus XR 4 mg tablets. The award was issued by the Defense Logistics Agency (DLA), which is a defense agency, and does not have a set-aside designation. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
- SPE2DB22D3004Indefinite Delivery Contract
- SPE2DB22D3004-SPE2DB24FQT33Delivery Order
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The $1,216.11 firm-fixed-price delivery order is for the pharmaceutical product Envarsus XR 1 mg tablet, with a completion date of July 8, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to support the Department of Defense's military treatment programs and facilities worldwide. The company also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024. This contract award does not have a set-aside designation, indicating it was awarded on a full and open competition basis. As a major supplier of pharmaceutical products and medical supplies to the federal government, Amerisourcebergen leverages its extensive supply chain capabilities to efficiently fulfill these types of government contracts.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 6/13/24 |